Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary
In 2010 the Institute of Medicine (IOM) recommended a framework for the evaluation of biomarkers in the chronic disease setting. Published in the book Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease, the framework is intended to bring consistency and transparency to the previousl...
Main Author: | |
---|---|
Corporate Author: | |
Other Authors: | , |
Format: | eBook |
Language: | Inglés |
Published: |
Washington, D.C. :
National Academies Press
2011.
|
Edition: | 1st ed |
Subjects: | |
See on Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622382706719 |
Table of Contents:
- Introduction
- Committee findings and recommendations
- FDA perspectives
- National institutes of health perspectives
- Industry perspectives
- Public health, consumer, and consulting organization perspectives
- Presentation by Thomas Fleming: biomarkers and surrogate endpoints in chronic disease
- Key themes, challenges, and opportunities
- Importance of the biomarker discussion forum.